ANN ARBOR – Epidemiologist Fred Brown returns to update what’s the current and projected situation for the COVID-19 mutation dubbed Omicron. Fred consults with the FDA, many US states and nations to advise them on healthcare measures that need to be taken to minimize the spread of the pandemic.
Trained as a medicinal biochemist, Brown has been on the discovery, development and/or launch teams of 27 major pharmaceutical, 13 diagnostic and 6 vaccine products. Collectively, these products save the lives of over 5.6 million people annually and generated over $35B of revenue in 2020.
Brown comes to the fight against COVID-19 from a forty year career developing pharmaceutical solutions to fight infectious diseases and solving the myriad challenges involved in suppressing epidemics including HIV, H5N1, Ebola, Zika, measles and malaria. His extensive experience managing past pandemics are accelerating and supporting personal, business and government responses to COVID-19 around the world.
